Martin M, Rodriguez-Lescure A, Reboredo C, Chen E, et al. Sensitivity to endocrine therapy index predicts benefit from weekly adjuvant paclitaxel for hormone receptor-positive breast cancer in the GEICAM/9906 trial. Clin Cancer Res 2026 May 26. doi: 10.1158/1078-0432.CCR-26-0177.
PMID: 42189890